ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as diaspartate - תמיסה להזרקה - pasireotide as diaspartate 0.3 mg/ml - pasireotide - pasireotide - treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as diaspartate - תמיסה להזרקה - pasireotide as diaspartate 0.6 mg/ml - pasireotide - pasireotide - treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.

ישראל - עברית - Ministry of Health

medison pharma ltd - pasireotide as diaspartate - תמיסה להזרקה - pasireotide as diaspartate 0.9 mg/ml - pasireotide - pasireotide - treatment of adult patients with cushing’s disease for whom surgery is not an option or for whom surgery has failed.

ישראל - עברית - Ministry of Health

medison pharma ltd - daptomycin 500 mg/vial - lyophilized powder for injection - daptomycin - cubicin (daptomycin for injection) is indicated for the treatment of complicated skin and skin structure infections caused by susceptible strains of the following gram-positive microorganisms: staphylococcus aureus (including methicillin-resistant strains) streptococcus pyogenes streptococcus agalactiae streptococcus dysgalactiae subsp. equisimilis and enterococcus faecalis (vancomycin-susceptible strains only). combination therapy may be clinically indicated if the documented or presumed pathogens include gram-negative or anaerobic organisms. daptomycin is not indicated for the treatment of pneumonia. appropriate specimens for microbiological examination should be obtained in order to isolate and identify the causative pathogens and to determine their susceptibility to daptomycin. empiric therapy may be initiated while awaiting test results. antimicrobial therapy should be adjusted as needed based upon test results. to reduce the development of drug-resistant bacteria and maintain the effectiveness of cubici

ישראל - עברית - Ministry of Health

medison pharma ltd - triptorelin as acetate - אבקה וממס להכנת תרחיף להזרקה - triptorelin as acetate 3.75 mg/vial - triptorelin - triptorelin - prostate cancer: treatment of prostate cancer with metastases. patients who have not previously received hormone therapy show a more marked response to the treatment and respond more frequently if the patient has not previously receieved another hormone treatment. precocious puberty: (before 8 years in girls and 10 years in boys). genital and extragenital endometriosis (stage i to stage iv): treatment should not be administered for more than 6 months. it is not recomended to start a second treatment course with triptorelin or another gnrh analogue. treatment of uterine fibromyomas prior to surgery: associated with anaemia ( haemoglobin less than, or equal to 8 g/dl). when a reduction in the size of the fibromyoma is necessary to facilitate or modify the surgical technique: endoscopic surgery, transvaginal surgery. the treatment duration is restricted to 3 months. female infertility: supplementary treatment in combination with gonadotrophins (hmg, fsh, hcg) to induce ovulation with a view to in vitro fertilisa

ישראל - עברית - Ministry of Health

medison pharma ltd - triptorelin as acetate - אבקה וממס להכנת תמיסה להזרקה - triptorelin as acetate 0.1 mg/vial - triptorelin - triptorelin - female infertility: management of ovarian stimulation in association with the gonadotrophins (hmg, fsh, hcg) in view of in vitro fertilisation and embrio transfer (i.v.f.e.t.) and other assisted conception techniques.

ישראל - עברית - Ministry of Health

medison pharma ltd - dextromethorphan hydrobromide; quinidine sulfate - קפסולות - quinidine sulfate 10 mg; dextromethorphan hydrobromide 20 mg - quinidine

ישראל - עברית - Ministry of Health

medison pharma ltd - telotristat ethyl as etiprate - טבליות מצופות פילם - telotristat ethyl as etiprate 250 mg

ישראל - עברית - Ministry of Health

medison pharma ltd - setmelanotide - תמיסה להזרקה - setmelanotide 10 mg / 1 ml

ישראל - עברית - Ministry of Health

medison pharma ltd - galsulfase - תרכיז להכנת תמיסה לאינפוזיה - galsulfase 1 mg/ml - galsulfase - galsulfase - naglazyme is indicated for long-term enzyme replacement therapy in patients with a confirmed diagnosis of mpsvi (n-acetylglactosamine 4 sulfatase deficiency maroteaux-lamy syndrome).